NCT02905578 2025-08-27
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
University of Iowa
Phase 2 Completed
University of Iowa
Thomas Jefferson University
University of Iowa
Bruckner Oncology
Fudan University
Weill Medical College of Cornell University
Zhongnan Hospital
University of Iowa